FDA Drug Policy Office Reshuffled Over ‘Spousal Employment’ Conflict
This article was originally published in The Pink Sheet Daily
Jonathan Jarow moves from Office of Medical Policy to Office of the Center Director; Califf has been meeting individually with members of Senate HELP committee.
You may also be interested in...
Jacqueline Corrigan-Curay joins from the National Heart, Lung and Blood Institute, where she worked on clinical trial initiatives and served as an NIH representative on FDA’s Drug Safety Oversight Board.
Former Novartis exec to join FDA in November.
FDA’s Center for Drugs continues to operate under a staffing shortage at a time when it faces tremendous pressure to implement new authorities. In some cases, that’s left Janet Woodcock scrambling to find senior managers that can lead top CDER initiatives. Direct hiring authority has helped, but it doesn’t fully address FDA’s recruiting challenges. There’s still too much red tape – and not enough money.